Akorn Recalls PerioRx Oral Rinse Due to Unknown Impurity
Akorn, Inc. is recalling PerioRx oral rinse because multiple batches failed impurity specifications. The product contains an unknown impurity of chlorhexidine gluconate.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score under the rubric for drug recalls involving potential health risks.
Plain-English summary
Akorn, Inc. is recalling PerioRx (chlorhexidine gluconate) oral rinse, 0.12%, packaged in 16 fl. oz. (473 mL) PET bottles. The recall affects 294,090 mL of the product, which was distributed nationwide and in Puerto Rico. The product is prescription-only and was manufactured for Discus Dental, LLC.
The recall was initiated because multiple batches of the product failed impurity and degradation specifications. Specifically, out-of-specification results were found for an unknown impurity of chlorhexidine gluconate. The affected lots include # 627525, 628362, 628595, 629319, 629885, 630467, 32218, 632500, 633075, 632799, 345624, 345679, 347420, and 347662, with expiration dates ranging from May 2016 to September 2017.
Consumers and healthcare providers should check their inventory for the specific lot numbers and expiration dates listed above. If the product matches the recalled lots, it should be returned to the pharmacy or point of purchase for a refund or replacement. Patients should consult their healthcare provider for alternative treatment options if they have been using the recalled product.
The recalled product
- Product
- PerioRx (chlorhexidine gluconate), oral rinse, 0.12%, packaged in 16 fl. oz. (473 mL) PET bottle, Rx only, Manufactured for Discus Dental, LLC, Ontario, CA 91761, UPC 4235 020 91701
- Manufacturer
- Akorn, Inc.
- Category
- Drug — Oral Rinse
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot # 627525
- Exp 5/16
- 628362
- Exp 6/16
- 628595
- Exp 7/16
- 629319
- Exp 8/16
- 629885
- Exp 9/16
- 630467
- Exp10/16
- 32218
- 632500
- Exp 2/17
- 633075
- 632799
- Exp 3/17
- 345624
- 345679
Distribution
Part of a larger recall action
This product is one of 3 recalled by Akorn, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Akorn, Inc.
See all →- HighGuaifenesin Oral Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighAkorn Hydromorphone Hydrochloride Injection Recalled Due to CGMP Deviations
FDA (Drugs) · 2023-06-07
- HighFDA Recalls Calcitriol Injection Due to Manufacturing Practice Violations
FDA (Drugs) · 2023-06-07
- HighTobramycin Ophthalmic Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighMidazolam Injection Recalled Due to Manufacturing Compliance and Stability Study Issues
FDA (Drugs) · 2023-06-07
Same hazard · impurity
See all →- ModerateHikma Recalls Ramipril Capsules Due to Process Impurity
FDA (Drugs) · 2026-09-02
- ModerateMedline Remedy Specialized Silicone Cream Recalled for Elevated Formaldehyde Levels
FDA (Drugs) · 2026-07-15
- SevereCinacalcet Hydrochloride Tablets Recalled for Elevated Impurity Levels
FDA (Drugs) · 2026-07-08
- HighDuloxetine 30mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17
- HighDuloxetine 60mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17